Calcyphosine 2 anticorps (Center)

N° du produit ABIN1887723

Détail du produit anti-Calcyphosine 2 anticorps

Antigène: Calcyphosine 2 (CAPS2)

Épitope: Center

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Calcyphosine 2 est non-conjugé

Application: ELISA, Western Blotting (WB), Immunohistochemistry (IHC)

Specificité: This CAPS2 antibody is predicted to be specific to CAPS2 and not recognize CAPS1.

Purification: Affinity chromatography purified via peptide column

Immunogène: 19 amino acid peptide near the center of the human CAPS2.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

Conseil sur la manipulation: Avoid freezing and thawing repeatly.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term use.Store at -20 °C for long term preservation.

Détails sur Calcyphosine 2

Antigène: Calcyphosine 2 (CAPS2)

Autre désignation: CAPS2 (CAPS2 Produits)

Synonymes: anticorps D630005B03Rik, anticorps CAPS2, anticorps calcyphosine 2, anticorps calcyphosphine 2, anticorps CAPS2, anticorps Caps2, anticorps caps2

Sujet: CAPS2 and the related protein CAPS1 encode novel neural/endocrine-specific cytosolic and peripheral membrane proteins.Both are essential components of the synaptic vesicle priming machinery and are required for the Ca2+-regulated exocytosis of secretory vesicles, CAPS-deficient neurons contain no or very few fusion competent synaptic vesicles, causing a selective impairment of fast phasic transmitter release.Like CAPS1, numerous isoforms of CAPS2 are known to exist.These isoforms show distinct expression patterns in the brain.For example, CAPS2b showed high expression in the developing cerebellum.Furthermore, one version of CAPS2 mRNA that lacks exon 3 is detected in some autistic patients, suggesting that the differential expression pattern of CAPS2 is involved in neuronal development.
Synonyms: Calcium-dependent secretion activator 2, CADPS2

NCBI Accession: NP_060424